Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06630676 · ClinicalTrials.gov registry record · NA

The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain

A NA study of Chronic Low Back Pain, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
269
Enrollment target
1
Study location

NCT06630676: Recruiting NA study of Chronic Low Back Pain, sponsored by Northwestern University.

NCT06630676 is a NA study of Chronic Low Back Pain that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 269 participants, below the 588-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06630676, a NA study of Chronic Low Back Pain, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
269 participants
Enrollment target
1
Study location

Study Summary

The investigative team will provide 27 slides with bullet points and images of pain referral patterns for different causes (e.g., herniated disc, facet joint arthritis) for patients seen for a new visit with a chief complaint of chronic low back pain. This material is all publicly available but has been compiled in presentation form. This will have educational benefit for patients, discussing clinical signs and symptoms, risk factors and basic treatments. There will also be a smaller control group of that gets a condensed 4-slide presentation. After review of the slides, an independent observer will ask the patient what they think are the 2 most likely causes of their LBP (in order of likelihood) and match that with the attending physician and trainee, who will independently do the same. The investigative team will then determine how concordant the patient's answers are with the physicians and also record outcomes.

Primary Outcome

Concordance (overlap) between the patient's guess at their top 2 diagnoses, and those rendered by the attending physician. The patient's choices include 12 diagnoses (e.g., discogenic pain, spinal stenosis, piriformis syndrome) while the physician's includes 13 (secondary gain).

Conditions Studied

Interventions

  • BEHAVIORAL Education
  • BEHAVIORAL Control

Study Locations (1)

Illinois

  • Northwestern University Pain Management Center - Chicago

Trial Details

FieldValue
Enrollment Target 269 participants
Start Date 2024-10-16
Est. Completion 2026-10-01
Phase NA
Northwestern University

1,209 total trials

What NCT06630676 shows while recruiting

NCT06630676 is an interventional study that assigns participants to a tested intervention. The registered 269 participants enrollment target is mid-sized for trials with a published cap, below the 588-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Education is the first listed.

NCT06630676 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06630676 about?

NCT06630676 is a clinical study titled "The Ability of Chronic Pain Patients to Self-diagnose Their Chief Source of Low Back Pain". The investigative team will provide 27 slides with bullet points and images of pain referral patterns for different causes (e.g., herniated disc, facet joint arthritis) for patients seen for a new visit with a chief complaint of chronic low back pain. This material is all publicly available but has ...

What is the current status of trial NCT06630676?

This trial is currently recruiting. It is a NA study. The enrollment target is 269 participants. The study started on 2024-10-16. Estimated completion is 2026-10-01.

What conditions does trial NCT06630676 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT06630676?

The interventions under investigation include: Education (BEHAVIORAL), Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT06630676?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06630676 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06630676's enrollment target sits among peer trials

269 18th of 71 higher than 54 of 71 other Chronic Low Back Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04802291 · 269 participants · NA

    HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity

  • NCT06500455 · 269 participants · Phase 3

    Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

  • NCT00801489 · 270 participants · Phase 2

    Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  • NCT04372485 · 270 participants · NA

    Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06630676, the US trial registry maintained by the National Library of Medicine. NCT06630676 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.